Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699962 | Clinical Oncology | 2011 | 6 Pages |
Abstract
This is the first report of three-dimensional high dose rate IGBT for the treatment of cervical cancer using a hybrid MRI/CT approach. Early results have shown the feasibility of this approach with excellent local control. Additional studies are needed to assess long-term outcomes of local control and associated morbidities.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Beriwal, N. Kannan, H. Kim, C. Houser, R. Mogus, P. Sukumvanich, A. Olawaiye, S. Richard, J.L. Kelley, R.P. Edwards, T.C. Krivak,